Clinicians can now prioritize which alarms they wish to have forwarded based upon various parameters they can choose. The core function allows a network based alarm message from an infusion pump to be forwarded to Connexall for intelligent routing based upon a customized workflow.
BOULDER, CO & TORONTO, ON (PRWEB) March 06, 2018
Connexall, the industry leader in alarm management and event notification, ranking number one in the 2018 Best in KLAS awards, and ICU Medical, a worldwide leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, are proud to announce the successful integration of ICU Medical MedNet to the Connexall alarm management and event notification platform. This integration allows hospitals to transmit and selectively filter the secondary alarms from several of ICU Med’s infusion pumps.
Clinicians can now prioritize which alarms they wish to have forwarded based upon various parameters they can choose. The core function allows a network based alarm message from an infusion pump to be forwarded to Connexall for intelligent routing based upon a customized workflow. Secondary alerting and distribution will serve to extend clinical awareness, improve response times, and reveal innovative ways to reduce alarm fatigue.
“We are pleased to collaborate with ICU Medical to provide this crucial integration to hospitals.” stated David Tavares, CEO of Globestar/Connexall. “Our customers frequently request delivery of time-sensitive notifications to mobile care givers from their infusion devices. Through this collaboration we are now able to meet that critical need.” continued Tavares.
“We are proud to include Connexall as a part of our growing list of connectivity partners. By integrating with alert management software, we can expand the clinician’s visibility to infusion delivery, help with response times, and support quiet hospital initiatives,’’ said Matthew Hutchings, senior director of ICU Medical IV Informatics. “When combined with the accuracy of data and secondary infusion alarming of the 2018 Best in KLAS Plum 360, we are delivering a winning combination of technologies.”
To learn more about this progressive solution, please visit ICU Medical at Booth #756 and Connexall at Booth #8105 at HIMSS18.
Connexall, ranked number one and named Category Leader in the 2015/2016, 2017, and 2018 Best in KLAS awards, is an enterprise-grade event management and control platform that delivers hospital-wide interoperability to people, systems, tasks, and devices. Its capabilities act as a backbone for clinical workflow, communicating the right information to the right person, at the right time, on the right device. Based on more than 20 years of R&D efforts, the Class II medical device software is completely vendor-neutral and device-independent. Connexall has offices in Canada, the United States, Brazil, Portugal and Hong Kong and works with well over a thousand of the world’s most renowned and progressive hospitals and health systems. For more information please visit http://www.connexall.com.
About ICU Medical
ICU Medical, Inc. (Nasdaq: ICUI) is one of the world's leading pure-play infusion therapy companies with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, the company manufactures automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. ICU Medical is headquartered in San Clemente, California. On February 3, 2017, ICU Medical completed the acquisition of the Hospira Infusion Systems business from Pfizer. More information about ICU Medical, Inc. can be found at http://www.icumed.com.
ICU Medical Contact: